title: Internalization of hydroxyapatite nanoparticles in liver cancer cells.
abstract: Hydroxyapatite (HAP) is the main inorganic component of hard tissues and shows excellent biocompatibility and osteoconductivity properties. Nanoparticles of HAP can be synthesised by the precipitation method in distilled water. The needle shaped particles are below 100 nm in size with low-crystallinity and high-surfacial activation. Recent studies showed toxic effects of HAP nanoparticles on cancer cells. Other studies focus on the application of HAP nanoparticles as drug and gene delivery system or cell marker. However, to date, the exact internalization pathway of HAP nanoparticles into cells has not been determined. When HAP nanoparticles were added to cell culture medium, the particles immediately became instable and formed agglomerates with a size of about 500-700 nm. Hence, cells seldom encounter single HAP nanoparticles in the environment of cell culture or body fluid. The TEM showed internalized HAP captured by vacuoles in the cytoplasm of the hepatocellular carcinoma cells. The invaginations in the cell membrane before nanoparticle uptake suggested endocytic pathways as internalization mechanism. This study revealed that agglomerated HAP nanoparticles were internalized by cells through the energy-dependent process of clathrin-mediated endocytosis. Depletion of intracellular potassium arrested the formation of coated pit, which inhibited the uptake of HAP.
authors: Biomedical Materials and Engineering Research Center, Wuhan University of Technology, Luoshi Road 122#, Wuhan 430070, P.R. China. iwb78@web.de
authors: Ingo Werner
authors: IW
authors: Bauer
authors: Shi-Pu
authors: SP
authors: Li
authors: Ying-Chao
authors: YC
authors: Han
authors: Lin
authors: L
authors: Yuan
authors: Mei-Zhen
authors: MZ
authors: Yin
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D002966:Clathrin / Q000378:metabolism; D003034:Coated Pits, Cell-Membrane / Q000187:drug effects / Q000378:metabolism; D016503:Drug Delivery Systems; D017886:Durapatite / Q000737:chemistry / Q000493:pharmacokinetics*; D006801:Humans; D007834:Lasers; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles; D010316:Particle Size; D011188:Potassium / Q000494:pharmacology; D012542:Scattering, Radiation; D014407:Tumor Cells, Cultured
chemical_list: D002966:Clathrin; D017886:Durapatite; D011188:Potassium
references: J Biol Chem. 1995 Aug 11;270(32):18997-9007
references: 7642560
references: J Bone Joint Surg Br. 2005 Aug;87(8):1050-4
references: 16049237
references: J Lipid Res. 2002 Dec;43(12):2095-104
references: 12454271
references: J Biol Chem. 2004 Oct 1;279(40):41991-7
references: 15292270
references: J Cell Biol. 1993 Mar;120(6):1449-59
references: 8449988
references: J Mater Sci Mater Med. 2005 Mar;16(3):189-95
references: 15744609
references: Biochemistry. 1996 May 7;35(18):5616-23
references: 8639519
references: Biochem J. 2004 Jan 1;377(Pt 1):159-69
references: 14505488
references: J Cell Biol. 1994 Nov;127(3):725-35
references: 7962055
references: Biochim Biophys Acta. 2002 Feb 18;1560(1-2):25-36
references: 11958773
references: Acta Orthop Scand. 1990 Aug;61(4):299-306
references: 2402977
references: Microbes Infect. 2001 Jul;3(9):755-61
references: 11489424
references: Pharmacol Rev. 2002 Sep;54(3):431-67
references: 12223531
references: Mol Ther. 2005 May;11(5):801-10
references: 15851018
references: J Gen Virol. 1998 Jun;79 ( Pt 6):1469-77
references: 9634090
references: J Biotechnol. 1999 Apr 15;69(2-3):125-33
references: 10361722
references: J Biomed Mater Res A. 2003 Dec 15;67(4):1228-37
references: 14624509
references: Biochim Biophys Acta. 2002 Aug 15;1572(1):67-76
references: 12204334
references: J Mater Sci Mater Med. 2004 Apr;15(4):413-8
references: 15332609
references: J Mater Sci Mater Med. 2003 Jun;14(6):511-9
references: 15348435
references: Mol Biol Cell. 1997 Jan;8(1):47-57
references: 9017594
references: Gene Ther. 2001 Aug;8(15):1188-96
references: 11509950